Tang Capital Management’s Dianthus Therapeutics DNTH Stock Holding History

Tang Capital Management’s Portfolio DNTH Stock Details DNTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$22.2M	Hold	264,692	–	–	1.13%	22
2025 Q4	$10.9M	Hold	264,692	–	–	0.54%	35
2025 Q3	$10.4M	Hold	264,692	–	–	0.4%	64
2025 Q2	$4.93M	Hold	264,692	–	–	0.25%	84
2025 Q1	$4.8M	Hold	264,692	–	–	0.27%	75
2024 Q4	$5.77M	Hold	264,692	–	–	0.38%	64
2024 Q3	$7.25M	Hold	264,692	–	–	0.52%	57
2024 Q2	$6.85M	Hold	264,692	–	–	0.7%	45
2024 Q1	$7.94M	Sell	264,692 -239,550	-48%	-$5.21M	0.83%	42
2023 Q4	$5.24M	Sell	504,242 -87,394	-15%	-$965K	0.48%	52
2023 Q3	$8.09M	Buy	591,636 +212,886	+56%	+$2.68M	1.14%	29
2023 Q2	$4.59M	Buy	378,750 +625	+0.2%	+$7.11K	0.68%	40
2023 Q1	$4.81M	Buy	+378,125	New	+$4.19M	0.72%	44

Other funds holding DNTH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Tang Capital Management's DNTH Position: Q1 2026 in Review

Tang Capital Management held its Dianthus Therapeutics (DNTH) position steady in Q1 2026 at 264,692 shares worth $22.2M. The position accounts for 1.13% of the portfolio, ranked #22.

Tang Capital Management first reported a position in DNTH in Q1 2023 and has held it in 13 quarters since. 241 funds tracked by Wall St. Rank hold DNTH as of Q1 2026.

Tang Capital Management held 264,692 shares of Dianthus Therapeutics worth $22.2M as of Q1 2026.
Tang Capital Management left its Dianthus Therapeutics share count unchanged in Q1 2026.
Dianthus Therapeutics made up 1.13% of Tang Capital Management's portfolio in Q1 2026, its #22 holding.
Tang Capital Management first reported a position in Dianthus Therapeutics in Q1 2023 and has held it in 13 quarters since.
241 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q1 2026.

Based on Tang Capital Management's 13F filing for Q1 2026, filed 15 May 2026.